Results overview: Found 2 records in 0.02 seconds.
Articles, 2 records found
Articles 2 records found  
1.
18 p, 851.1 KB Clinical outcome measures in dementia with Lewy bodies trials : critique and recommendations / Rodriguez-Porcel, Federico (Medical University of South Carolina) ; Wyman-Chick, Kathryn A. (HealthPartners) ; Abdelnour, Carla (Universitat Autònoma de Barcelona) ; Toledo, Jon B. (University of Florida) ; Ferreira, Daniel (Mayo Clinic) ; Urwyler, Prabitha (University of Bern) ; Weil, Rimona S. (University College London) ; Kane, Joseph (Queen's University) ; Pilotto, Andrea (University of Brescia) ; Rongve, Arvid (The University of Bergen) ; Boeve, Bradley (Mayo Clinic) ; Taylor, John-Paul (Newcastle University) ; McKeith, Ian (Newcastle University) ; Aarsland, Dag (King's College London) ; Lewis, Simon J. G. (University of Sydney)
The selection of appropriate outcome measures is fundamental to the design of any successful clinical trial. Although dementia with Lewy bodies (DLB) is one of the most common neurodegenerative conditions, assessment of therapeutic benefit in clinical trials often relies on tools developed for other conditions, such as Alzheimer's or Parkinson's disease. [...]
2022 - 10.1186/s40035-022-00299-w
Translational Neurodegeneration, Vol. 11 (may 2022)  
2.
1 p, 574.4 KB Correction : Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations / Rodriguez-Porcel, Federico (Medical University of South Carolina) ; Wyman-Chick, Kathryn A. (HealthPartners) ; Abdelnour, Carla (Universitat Autònoma de Barcelona) ; Toledo, Jon B. (University of Florida) ; Ferreira, Daniel (Mayo Clinic) ; Urwyler, Prabitha (University of Bern) ; Weil, Rimona S. (University College London) ; Kane, Joseph (Queen's University) ; Pilotto, Andrea (University of Brescia) ; Rongve, Arvid (The University of Bergen) ; Boeve, Bradley (Mayo Clinic) ; Taylor, John-Paul (Newcastle University) ; McKeith, Ian (Newcastle University) ; Aarsland, Dag (King's College London) ; Lewis, Simon J. G. (University of Sydney)
The selection of appropriate outcome measures is fundamental to the design of any successful clinical trial. Although dementia with Lewy bodies (DLB) is one of the most common neurodegenerative conditions, assessment of therapeutic benefit in clinical trials often relies on tools developed for other conditions, such as Alzheimer's or Parkinson's disease. [...]
2022 - 10.1186/s40035-022-00306-0
Translational Neurodegeneration, Vol. 11 (may 2022)  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.